Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2011, Article ID 835410, 9 pages
http://dx.doi.org/10.1155/2011/835410
Review Article

Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity

1Department of Pathology, University of Texas Medical School at Houston, 6431 Fannin, Houston, TX 77030, USA
2Department of Integrative Biology and Pharmacology, University of Texas Medical School at Houston, 6431 Fannin, Houston, TX 77030, USA
3Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, MSB 2.214 6431 Fannin, Houston, TX 77030, USA

Received 1 November 2010; Revised 19 January 2011; Accepted 1 March 2011

Academic Editor: Carlo Garzelli

Copyright © 2011 Shen-An Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Shen-An Hwang, Kerry J. Welsh, Sydney Boyd, Marian L. Kruzel, and Jeffrey K. Actor, “Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen,” Tuberculosis, vol. 91, pp. S90–S95, 2011. View at Publisher · View at Google Scholar
  • J. S. Sutherland, A. G. Loxton, M. C. Haks, D. Kassa, L. Ambrose, J.-S. Lee, L. Ran, D. van Baarle, J. Maertzdorf, R. Howe, H. Mayanja-Kizza, W. H. Boom, B. A. Thiel, A. C. Crampin, W. Hanekom, M. O. C. Ota, H. Dockrell, G. Walzl, S. H. E. Kaufmann, and T. H. M. Ottenhoff, “Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity,” Clinical Microbiology and Infection, 2013. View at Publisher · View at Google Scholar
  • Avinash Padhi, Mitali Sengupta, Srabasti Sengupta, Klaus H. Roehm, and Avinash Sonawane, “Antimicrobial peptides and proteins in mycobacterial therapy: Current status and future prospects,” Tuberculosis, vol. 94, no. 4, pp. 363–373, 2014. View at Publisher · View at Google Scholar
  • Tania Siqueiros-Cendon, Sigifredo Arevalo-Gallegos, Blanca Flor Iglesias-Figueroa, Isui Abril Garcia-Montoya, and Jose Salazar-Martinez, “Immunomodulatory effects of lactoferrin,” Acta Pharmacologica Sinica, vol. 35, no. 5, pp. 557–566, 2014. View at Publisher · View at Google Scholar
  • Alla I. Yemets, Iryna V. Tanasienko, Yuliya A. Krasylenko, and Yaroslav B. Blume, “Plant-based biopharming of recombinant human lactoferrin,” Cell Biology International, 2014. View at Publisher · View at Google Scholar
  • Adane Mihret, Andre G. Loxton, Yonas Bekele, Stefan H. E. Kaufmann, Martin Kidd, Marielle C. Haks, Tom H. M. Ottenhoff, Abraham Aseffa, Rawleigh Howe, and Gerhard Walzl, “Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states,” Bmc Infectious Diseases, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Shen-An Hwang, Marian L. Kruzel, and Jeffrey K. Actor, “Effects of CHO-expressed recombinant lactoferrins on mouse dendritic cell presentation and function,” Innate Immunity, vol. 21, no. 5, pp. 553–561, 2015. View at Publisher · View at Google Scholar
  • Shen-An Hwang, Marian L. Kruzel, and Jeffrey K. Actor, “CHO expressed recombinant human lactoferrin as an adjuvant for BCG,” International Journal Of Immunopathology And Pharmacology, vol. 28, no. 4, pp. 452–468, 2015. View at Publisher · View at Google Scholar
  • Shen-An Hwang, Marian L. Kruzel, and Jeffrey K. Actor, “ Oral recombinant human or mouse lactoferrin reduces Mycobacterium tuberculosis TDM induced granulomatous lung pathology 1 ,” Biochemistry and Cell Biology, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Vladimir Lopez, Margarita Villar, Joao Queiros, Joaquin Vicente, Lourdes Mateos-Hernandez, Iratxe Diez-Delgado, Marinela Contreras, Paulo C. Alves, Pilar Alberdi, Christian Gortazar, and Jose de la Fuente, “Comparative Proteomics Identifies Host Immune System Proteins Affected by Infection with Mycobacterium bovis,” Plos Neglected Tropical Diseases, vol. 10, no. 3, 2016. View at Publisher · View at Google Scholar
  • Ivonne Maciel Arciniega-Martinez, Rafael Campos-Rodriguez, Maria Elisa Drago-Serrano, Luvia Enid Sanchez-Torres, Teresita Rocio Cruz-Hernandez, and Aldo Arturo Resendiz-Albor, “Modulatory Effects of Oral Bovine Lactoferrin on the IgA Response at Inductor and Effector Sites of Distal Small Intestine from BALB/c Mice,” Archivum Immunologiae Et Therapiae Experimentalis, vol. 64, no. 1, pp. 57–63, 2016. View at Publisher · View at Google Scholar
  • Marian L. Kruzel, Michal Zimecki, and Jeffrey K. Actor, “Lactoferrin in a Context of Inflammation-Induced Pathology,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar